Can Wall Street Cure Cancer?
MIT Sloan professor Andrew Lo is calling for an investable "mega-fund" for cancer research.
China Adds Hurdles for International Pharma Firms
Investors in the Chinese pharmaceutical sector might want to have another look at some of their investments under toughened laws.
SEC Enforcement: Fund Manager Charged With Defrauding Fellow Church Members
In other actions, the SEC fined Rafferty Capital Markets for facilitating trades for an unregistered firm.
Government Shutdown Ends, Debt Default Averted
Federal employees began returning to work on Thursday after the legislation passed both houses of Congress late Wednesday and was signed into law by President Barack Obama just after midnight.
James Margard of Rainier Small/Mid-Cap Equity Fund
S&P Rank: 3 Stars Growth at a Very Reasonable Price
Biotech Funds: Handle With Care
March 30, 2004 -- Biotech funds have been red-hot recently -- the average biotech fund shot up 50.5% for the one-year period through last month,...
Steve Calhoun of Fidelity Select Health Care Portf
Good Prognosis for Medical Devices S&P Rank:
Biotech Funds: Looking for a Cure in 2003
Jan. 31, 2003 -- By any measure, biotech stocks suffered a disastrous year in 2002. Mutual funds investing in biotech tracked by Standard & Poor's...